Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells

British Journal of Cancer

Volumn 91, Issue 1, 2004, Pages 178-185

  Zhang, S ^a   Cao, H J ^a   Davis, F B ^a   Tang, H Y ^b   Davis, P J ^a,b,c   Lin, H Y ^b  

^a ORDWAY RESEARCH INSTITUTE   (United States)

^b STRATTON VA MEDICAL CENTER   (United States)

^c WADSWORTH CENTER   (United States)

Author keywords

Apoptosis; Breast cancer; MCF 7 cells; Mitogen activated protein kinase; Oestrogen; p53; Resveratrol

Indexed keywords

DNA; DNA FRAGMENT; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN P21; PROTEIN P53; RESVERATROL; STILBENE; ANTINEOPLASTIC AGENT; RIBONUCLEOTIDE REDUCTASE; STILBENE DERIVATIVE;

ACETYLATION; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA DETERMINATION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; ESTROGEN ACTIVITY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PROCESSING; TRANSCRIPTION INITIATION; BREAST TUMOR; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; ESTRADIOL; FEMALE; HUMANS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RIBONUCLEOTIDE REDUCTASES; STILBENES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3343022920     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601902     Document Type: Article

References (37)

1. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR (1998) The p53 network. J Biol Chem 273: 1-4
2. Ashcroft M, Vousden KH (1999) Regulation of p53 stability. Oncogene 18: 7637-7643
3. Berlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD, Berger SL (2001) Acetylation of p53 activates transcription through recruitment of coactivators/histone acetytransferases. Mol Cell 8: 1243-1254
4. Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 61: 7456-7463
5. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM (2000) Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β. Endocrinology 141: 3657-3667
6. Burow ME, Weldon CB, Tang Y, McLachlan JA, Beckman BS (2001) Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. J Steroid Biochem Mol Biol 78: 409-418
7. Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM (2000) Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Proc Natl Acad Sci USA 97: 9042-9046
8. Cho DI, Koo NY, Chung WJ, Kim TS, Ryu SY, Im SY, Kim KM (2002) Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanism of action. Life Sci 71: 2071-2082
9. Clement M-V, Hirpara JL, Chawdhury S-H, Pervaiz S (1998) Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996-1002
10. Higashimoto Y, Saito S, Tong XH, Hong A, Sakaguchi K, Appella E, Anderson CW (2000) Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents. J Biol Chem 275: 23199-23203
11. Hsieh TC, Burfeind P, Laud K, Backer JM, Traganos F, Darzynkiewicz Z, Wu JM (1999) Cell cycle effects and control of gene expression by resveratrol in human breast cancer cell lines with different metastatic potentials. Int J Oncol 15: 245-252
12. Huang C, Ma WY, Goranson A, Dong Z (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20: 237-242
13. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220
14. Jeanet P, Bessis R, Gautheron B (1991) The production of resveratrol (3,5,4′-trihydroxystilbene) by grape berries in different stages. Am J Enol Viticul 42: 41-46
15. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Susaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 491-1494
16. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV (1998) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285: 1733-1737
17. Levenson AS, Gehm BD, Pearce ST, Horiguchi J, Simons LA, Ward III JE, Jameson JL, Jordan VC (2003) Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha. Int J Cancer 104: 587-596
18. Lin H-Y, Shih A, Davis FB, Tang H-Y, Martino LJ, Bennett JA, Davis PJ (2002) Resveratrol-induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J Urol 168: 748-755
19. Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD, Berger SL (1999) p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19: 1202-1209
20. Lu R, Serrero G (1999) Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol 179: 297-304
21. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15: 1292-1300
22. Pace-Asciak C, Hahn R, Diamandis EP, Soleas G, Goldberg DM (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary disease. Clin Chim Acta 235: 207-219
23. Papaconstantinou AD, Umbreit TH, Goering PL, Brown KM (2002) Effects of 17 alpha-methyltestosterone on uterine morphology and heat shock protein expression are mediated through estrogen and androgen receptors. J Steroid Biochem Mol Biol 82: 305-314
24. Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernandez-Salguero PM (2002) The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem Pharmacol 64: 1375-1386
25. Prives C, Manley JL (2001) Why is p53 acetylated? Cell 107: 815-818
26. Qi JS, Yuan Y, Desai-Yajnik V, Samuels HH (1999) Regulation of the mdm2 oncogene by thyroid hormone receptor. Mol Cell Biol 19: 864-872
27. Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, Levin ER (2003) Identification of a structural determinant necessary for the localization and function of estrogen receptor α at the plasma membrane. Mol Cell Biol 23: 1633-1646
28. Razandi M, Pedram A, Levin ER (2000) Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol Endocrinol 14: 1434-1447
29. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E (1998) DNA damage activates p53 through a phosphorylation - acetylation cascade. Genes Dev 12: 2831-2841
30. Santen RJ, Song RX, McPherson R, Kumar R, Adam L, Jeng MH, Yue W (2002) The role of mitogen-activated protein (MAP) kinase in breast cancer. J Steroid Biochem Mol Biol 80: 239-256
31. Sengupta S, Wasylyk B (2001) Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes Dev 15: 2367-2380
32. She QB, Bode AM, Ma WY, Chen NY, Dong Z (2001) Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61: 1604-1610
33. Shih A, Davis FB, Lin H-Y, Davis PJ (2002) Resveratrol induces apoptosis in thyroid cancer cell lines via a mitogen-activated protein kinase- and p53-dependent mechanism. J Clin Endo Metab 87: 1223-1232
34. Shih A, Lin HY, Davis FB, Davis PJ (2001) Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry 40: 2870-2878
35. Toillon RA, Chopin V, Jouy N, Fauquette W, Boilly B, Le Bourbis X (2002) Normal breast epithelial cells induce p53-dependent apoptosis and p53-independent cell cycle arrest of breast cancer cells. Breast Cancer Res Treat 71: 269-280
36. Wade CB, Dorsa DM (2003) Estrogen activation of cyclic adenosine 5′-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway. Endocrinology 144: 832-838
37. Zhang Z, Li M, Wang H, Agrawal S, Zhang R (2003) Antisense therapy targeting MDM2 oncogene in prostate cancer: effects on proliferation, apoptosis, multiple gene expression, and chemotherapy. Proc Natl Acad Sci USA 100: 11636-11641